2011
DOI: 10.1016/j.lungcan.2011.04.011
|View full text |Cite
|
Sign up to set email alerts
|

Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: Results from the Italian observational “SUN” (Survey on the lUng cancer maNagement) study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
8
0
3

Year Published

2012
2012
2017
2017

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 23 publications
1
8
0
3
Order By: Relevance
“…Platinum-based doublet chemotherapy was administered in all 7 studies that described the use of second-line combination chemotherapy regimens [13, 1517, 19, 21, 2426]. The most frequent use of combination chemotherapy was reported in a study that included only patients with squamous histology [26].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Platinum-based doublet chemotherapy was administered in all 7 studies that described the use of second-line combination chemotherapy regimens [13, 1517, 19, 21, 2426]. The most frequent use of combination chemotherapy was reported in a study that included only patients with squamous histology [26].…”
Section: Resultsmentioning
confidence: 99%
“…None of these studies provided information to explain why patients did not receive later lines of therapy. However, Gridelli et al reported that poor performance status and older age were the most common reasons patients did not receive first-line treatment [17]. These reasons, in addition to a poor response to first-line treatment, may be why patients with advanced NSCLC do not receive later lines of therapy.…”
Section: Discussionmentioning
confidence: 99%
“…Similar surveys have been conducted in other countries [10][11][12][13] however they reflect management practices in western countries and no studies have previously focused on the Asian NSCLC perspective. Our study emphasizes real clinical practice in the Chinese population for the first time.…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, in the firstline treatment gemcitabine/platinum was most often used which reflected as the typical European clinical practice [11,13], while in U.S. taxanes/platinum was predominately used [12]. Gridelli et al showed that 80% patients with pulmonary squamous cell carcinoma in Italy received gemcitabine/platinum initially, as did 54% with non-squamous cell carcinoma.…”
Section: Discussionmentioning
confidence: 99%
“…International existieren einige Untersuchungen zur Umsetzung von Leitlinien, in denen einzelne Therapiemodalitä-ten [3 -5] bzw. isolierte Tumorstadien betrachtet werden [6,7]. Die Analyse der Umsetzung von Leitlinienempfehlungen in Deutschland erfolgte erstmalig in Form einer Querschnittserhebung für das Bundesland Berlin.…”
unclassified